prasugrel + Clopidogrel
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus
Conditions
Diabetes Mellitus, Coronary Artery Disease
Trial Timeline
Apr 1, 2008 → Jan 1, 2009
NCT ID
NCT00642174About prasugrel + Clopidogrel
prasugrel + Clopidogrel is a phase 2 stage product being developed by Daiichi Sankyo for Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT00642174. Target conditions include Diabetes Mellitus, Coronary Artery Disease.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (10)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01327534 | Phase 3 | Completed |
| NCT01260584 | Approved | Completed |
| NCT01107912 | Phase 1 | Completed |
| NCT01107925 | Phase 1 | Completed |
| NCT01014624 | Approved | Completed |
| NCT00910299 | Phase 2 | Terminated |
| NCT00830960 | Phase 3 | Completed |
| NCT00642174 | Phase 2 | Completed |
| NCT00385944 | Phase 2 | Completed |
| NCT00097591 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetes Mellitus